Mixed fortunes in the treatment of Crohn's disease

The Lancet

Volumn 379, Issue 9832, 2012, Pages 2212-

  Walker, Gareth ^a   Venkatachalam, Prathima ^a   Bird, Jennifer ^a   Wilson, David ^a   Probert, Chris ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; FLUDARABINE; PREDNISOLONE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; B CELL LEUKEMIA; BACTERIAL INFECTION; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA REMISSION; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; NIGHT SWEAT; NOTE; PRIORITY JOURNAL; PROTOZOAL INFECTION; RELAPSE; REMISSION; VIRUS INFECTION; WEIGHT REDUCTION;

EID: 84861958671     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60359-6     Document Type: Article

References (5)

1. L Larvol, JC Soule, A Le Tourneau Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease N Engl J Med 331 1994 883 884
2. MA Behr, M Divangahi, JD Lalande What's in a name? The (mis)labelling of Crohn's as an autoimmune disease Lancet 376 2010 202 203
3. K Leiper, K Martin, A Ellis et al. Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis Gut 60 2011 1520 1526
4. KA Papadakis, B Rosenbloom, SR Targan Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease Gastroenterology 124 2003 583
5. RK Burt, RM Craig, F Milanetti et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn's disease: long-term follow-up Blood 116 2010 6123 6132